This CPEB3 down-regulation was accompanied by an increase in p-Akt and EGFR levels and a decrease in p21 levels, assigning a tumor-suppressor role for CPEB3 in a context of HCC. Here, CPEB3 is linked to hepatocellular carcinoma.